FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051279667> ?p ?o ?g. }

• W2051279667 endingPage "580" @default.
• W2051279667 startingPage "563" @default.
• W2051279667 abstract "Therapeutic HIV immunization is intended to induce new HIV-specific cellular immune responses and to reduce viral load, possibly permitting extended periods without antiretroviral drugs. A multigene, multi-subtype A, B, C HIV-DNA vaccine (HIVIS) has been used in clinical trials in both children and adults with the aim of improving and broadening the infected individuals' immune responses. Despite the different country locations, different regimens and the necessary variations in assays performed, this is, to our knowledge, the first attempt to compare children's and adults' responses to a particular HIV vaccine. Ten vertically HIV-infected children aged 4-16 years were immunized during antiretroviral therapy (ART). Another ten children were blindly recruited as controls. Both groups continued their antiretroviral treatment during and after vaccinations. Twelve chronically HIV-infected adults were vaccinated, followed by repeated structured therapy interruptions (STI) of their antiretroviral treatment. The adult group included four controls, receiving placebo vaccinations. The HIV-DNA vaccine was generally well tolerated, and no serious adverse events were registered in any group. In the HIV-infected children, an increased specific immune response to Gag and RT proteins was detected by antigen-specific lymphoproliferation. Moreover, the frequency of HIV-specific CD8+ T-cell lymphocytes releasing perforin was significantly higher in the vaccinees than the controls. In the HIV-infected adults, increased CD8+ T-cell responses to Gag, RT and viral protease peptides were detected. No augmentation of HIV-specific lymphoproliferative responses were detected in adults after vaccination. In conclusion, the HIV-DNA vaccine can elicit new HIV-specific cellular immune responses, particularly to Gag antigens, in both HIV-infected children and adults. Vaccinated children mounted transient new HIV-specific immune responses, including both CD4+ T-cell lymphoproliferation and late CD8+ T-cell responses. In the adult cohort, primarily CD8+ T-cell responses related to MHC class I alleles were noted. However, no clinical benefits with respect to viral load reduction were ascribable to the vaccinations alone. No severe adverse effects related to the vaccine were found in either cohort, and no virological failures or drug resistances were detected." @default.
• W2051279667 created "2016-06-24" @default.
• W2051279667 creator A5000628111 @default.
• W2051279667 creator A5004527390 @default.
• W2051279667 creator A5013181294 @default.
• W2051279667 creator A5015006071 @default.
• W2051279667 creator A5017248510 @default.
• W2051279667 creator A5019647556 @default.
• W2051279667 creator A5026539734 @default.
• W2051279667 creator A5030333997 @default.
• W2051279667 creator A5050257455 @default.
• W2051279667 creator A5055436202 @default.
• W2051279667 creator A5060350854 @default.
• W2051279667 creator A5069933412 @default.
• W2051279667 creator A5071730738 @default.
• W2051279667 creator A5072904584 @default.
• W2051279667 creator A5073981579 @default.
• W2051279667 creator A5074694529 @default.
• W2051279667 creator A5077241520 @default.
• W2051279667 creator A5078448043 @default.
• W2051279667 creator A5079172808 @default.
• W2051279667 creator A5090994819 @default.
• W2051279667 date "2014-07-17" @default.
• W2051279667 modified "2023-09-30" @default.
• W2051279667 title "Immunotherapy with an HIV-DNA Vaccine in Children and Adults" @default.
• W2051279667 cites W1136695336 @default.
• W2051279667 cites W1842249900 @default.
• W2051279667 cites W19488281 @default.
• W2051279667 cites W1965501933 @default.
• W2051279667 cites W1966696376 @default.
• W2051279667 cites W1969251048 @default.
• W2051279667 cites W1974355146 @default.
• W2051279667 cites W1978406852 @default.
• W2051279667 cites W1979989306 @default.
• W2051279667 cites W1980034936 @default.
• W2051279667 cites W1981386613 @default.
• W2051279667 cites W1983059051 @default.
• W2051279667 cites W1991585318 @default.
• W2051279667 cites W1995295820 @default.
• W2051279667 cites W1996900361 @default.
• W2051279667 cites W1998620074 @default.
• W2051279667 cites W2005588470 @default.
• W2051279667 cites W2014694744 @default.
• W2051279667 cites W2018792628 @default.
• W2051279667 cites W2019799215 @default.
• W2051279667 cites W2028101850 @default.
• W2051279667 cites W2030790110 @default.
• W2051279667 cites W2031831983 @default.
• W2051279667 cites W2032784200 @default.
• W2051279667 cites W2033009730 @default.
• W2051279667 cites W2037233238 @default.
• W2051279667 cites W2038474754 @default.
• W2051279667 cites W2043212172 @default.
• W2051279667 cites W2046335003 @default.
• W2051279667 cites W2048134422 @default.
• W2051279667 cites W2049614028 @default.
• W2051279667 cites W2059262899 @default.
• W2051279667 cites W2069792657 @default.
• W2051279667 cites W2071093060 @default.
• W2051279667 cites W2071592614 @default.
• W2051279667 cites W2079251499 @default.
• W2051279667 cites W2083742934 @default.
• W2051279667 cites W2088005860 @default.
• W2051279667 cites W2094109192 @default.
• W2051279667 cites W2097345834 @default.
• W2051279667 cites W2102992206 @default.
• W2051279667 cites W2104991487 @default.
• W2051279667 cites W2106431826 @default.
• W2051279667 cites W2107683840 @default.
• W2051279667 cites W2115625797 @default.
• W2051279667 cites W2119964825 @default.
• W2051279667 cites W2127549063 @default.
• W2051279667 cites W2130975388 @default.
• W2051279667 cites W2132519286 @default.
• W2051279667 cites W2135073267 @default.
• W2051279667 cites W2140258750 @default.
• W2051279667 cites W2146056675 @default.
• W2051279667 cites W2152641956 @default.
• W2051279667 cites W2161337335 @default.
• W2051279667 cites W2164684685 @default.
• W2051279667 cites W2166217494 @default.
• W2051279667 doi "https://doi.org/10.3390/vaccines2030563" @default.
• W2051279667 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4494215" @default.
• W2051279667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26344746" @default.
• W2051279667 hasPublicationYear "2014" @default.
• W2051279667 type Work @default.
• W2051279667 sameAs 2051279667 @default.
• W2051279667 citedByCount "10" @default.
• W2051279667 countsByYear W20512796672014 @default.
• W2051279667 countsByYear W20512796672015 @default.
• W2051279667 countsByYear W20512796672016 @default.
• W2051279667 countsByYear W20512796672018 @default.
• W2051279667 countsByYear W20512796672019 @default.
• W2051279667 countsByYear W20512796672021 @default.
• W2051279667 countsByYear W20512796672022 @default.
• W2051279667 crossrefType "journal-article" @default.
• W2051279667 hasAuthorship W2051279667A5000628111 @default.
• W2051279667 hasAuthorship W2051279667A5004527390 @default.

• next